- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Insights 72 results
Newsletter
April 29, 2026
Lender Liability Quarterly – April 2026
Client Alert
April 20, 2026
FDA Reminds Sponsors and Researchers to Disclose Clinical Trial Results to ClinicalTrials.gov
Article · Source: Bloomberg Law
April 2, 2026
Disclosure Tide Is Turning for Third-Party Litigation Funding
Article · Source: Option Finance
March 18, 2026
The Collapse in Software Publisher Valuations: A Crisis That Looks Like an Opportunity
Thought Leadership
February 27, 2026
2026 M&A Outlook: Examining the Impact of Megadeals, Private Equity, and Technology on M&A Market Momentum and Opportunity
Client Alert
February 16, 2026
FDA Issues Refuse-to-File Letter for mRNA-based Vaccine BLA
Newsletter
January 30, 2026
Lender Liability Quarterly - January 2026
Client Alert
January 15, 2026
FTC Announces 2026 Jurisdictional Threshold Updates for Interlocking Directorates and HSR Filing Thresholds
Client Alert
December 8, 2025
Exercising caution in relying on the ‘Obligors’ Agent’ construct
Article · Source: Thomson Reuters Westlaw Today
December 3, 2025
Deemed Fulfilment Dethroned: UK Supreme Court Gives Important Decision on Conditions Precedent
Client Alert
December 3, 2025
Deemed Fulfilment Dethroned: UK Supreme Court Gives Important Decision on Conditions Precedent
Newsletter
October 30, 2025
Lender Liability Quarterly October 2025